5W AI Index Reveals New Pharma Visibility Leaders Online
BOCA RATON, Fla., June 19, 2026 5W AI Communications has released its Pharma / Rx AI Visibility Index 2026,...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BOCA RATON, Fla., June 19, 2026 5W AI Communications has released its Pharma / Rx AI Visibility Index 2026,...
SAN DIEGO, June 18, 2026 Channel Robotics, a pioneering medical technology company developing a novel AI-enabled handheld endoscopic robotic...
PLYMOUTH MEETING, Pa., June 12, 2026 Braeburn has announced the presentation of new clinical and real-world research findings for...
SAN DIEGO, June 19, 2026 Fapon Biopharma and MOTE Therapeutics have announced plans to present their innovative dual-targeting, dual-platform...
BOSTON and ROLLE, Switzerland, June 19, 2026 SOPHiA GENETICS, a global leader in AI-driven precision medicine, has announced the...
RESEARCH TRIANGLE PARK, N.C., June 16, 2026 Simulations Plus, a global leader in model-informed and AI-accelerated drug development software,...
NEW YORK, June 16, 2026 AccurKardia announced that its AK-AVSâ„¢ aortic valve stenosis screening software has been accepted into...
BEVERLY, Mass., June 16, 2026 Akston Biosciences Corporation has announced promising preclinical data demonstrating that its investigational immunotherapeutic AKS-699...
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
